Ovarian cancer (OC) is the second most common gynecological malignancy and the fifth
leading cause of death due to cancer in women in the United States mainly due to the late …

While the mortality rates for many cancers have decreased due to improved detection and
treatments, that of pancreatic cancer remains stubbornly high. The microbiome is an …

Gynecologic cancers develop from the female reproductive organs. Microbial dysbiosis in
the gut and oral cavity can communicate with each other through various ways, leading to …

Background Several studies support the interplay between the urinary microbiome (ie,
urobiome) and bladder cancer (BCa). Specific urinary bacteria may be responsible for …

To date, the increased awareness of the impact of microbes on human health has promoted
scientific interest in microbiome studies for diagnostic and therapeutic purposes, revealing …

Objective: PhytoSERM is a selective estrogen receptor beta (ERβ) modulator comprised of
three phytoestrogens: genistein, daidzein, and S-equol. The PhytoSERM formulation …

In this study, the bacterial diversity of acquired middle ear cholesteatoma (MEC) was
evaluated to reveal its pathogenesis and provides a guide for the use of antibiotics. Twenty …

Objective The incidence of postmenopausal endometrial cancer (EC) is rising, and the
uterine microbiota has recently been suggested to be an etiology of EC. However, the …

It is increasingly recognized that the human immune response influences cancer risk,
progression, and survival; consequently, there is growing interest in the role of human …

Gut microbe dysbiosis increases repetitive inflammatory responses, leading to an increase
in the incidence of colorectal cancer. Recent studies have revealed that specific microbial …